» Articles » PMID: 19234585

Alpha-linolenic Acid Supplementation and Resistance Training in Older Adults

Overview
Date 2009 Feb 24
PMID 19234585
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Increased inflammation with aging has been linked to sarcopenia. The purpose of this study was to evaluate the effects of supplementing older adults with alpha-linolenic acid (ALA) during a resistance training program, based on the hypothesis that ALA decreases the plasma concentration of the inflammatory cytokine tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, which in turn would improve muscle size and strength. Fifty-one older adults (65.4 +/- 0.8 years) were randomized to receive ALA in flax oil (~14 g.day-1) or placebo for 12 weeks while completing a resistance training program (3 days a week). Subjects were evaluated at baseline and after 12 weeks for muscle thickness of knee and elbow flexors and extensors (B-mode ultrasound), muscle strength (1 repetition maximum), body composition (dual energy X-ray absorptiometry), and concentrations of TNF-alpha and IL-6. Males supplementing with ALA decreased IL-6 concentration over the 12 weeks (62 +/- 36% decrease; p = 0.003), with no other changes in inflammatory cytokines. Chest and leg press strength, lean tissue mass, muscle thickness, hip bone mineral content and density, and total bone mineral content significantly increased, and percent fat and total body mass decreased with training (p < 0.05), with the only benefit of ALA being a significantly greater increase in knee flexor muscle thickness in males (p < 0.05). Total-body bone mineral density improved in the placebo group, with no change in the ALA group (p = 0.05). ALA supplementation lowers the IL-6 concentration in older men but not women, but had minimal effect on muscle mass and strength during resistance training.

Citing Articles

Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?.

Al-Awadi A, Gray S, Al-Ozairi E Rev Endocr Metab Disord. 2025; .

PMID: 39998784 DOI: 10.1007/s11154-025-09947-8.


A 4-Week Mobile App-Based Telerehabilitation Program vs Conventional In-Person Rehabilitation in Older Adults With Sarcopenia: Randomized Controlled Trial.

Zhang L, Ge Y, Zhao W, Shu X, Kang L, Wang Q J Med Internet Res. 2025; 27:e67846.

PMID: 39854716 PMC: 11806269. DOI: 10.2196/67846.


Omega-3 Fatty Acids and Muscle Strength-Current State of Knowledge and Future Perspectives.

Tomczyk M Nutrients. 2024; 16(23).

PMID: 39683468 PMC: 11643269. DOI: 10.3390/nu16234075.


A comprehensive review on the risks assessment and treatment options for Sarcopenia in people with diabetes.

Johri N, Vengat M, Kumar D, Nagar P, John D, Dutta S J Diabetes Metab Disord. 2023; 22(2):995-1010.

PMID: 37975099 PMC: 10638272. DOI: 10.1007/s40200-023-01262-w.


The Influences of Macronutrients on Bone Mineral Density, Bone Turnover Markers, and Fracture Risk in Elderly People: A Review of Human Studies.

Je M, Kang K, Yoo J, Kim Y Nutrients. 2023; 15(20).

PMID: 37892460 PMC: 10610213. DOI: 10.3390/nu15204386.